The FDA announced on Feb. 26, 2014, that Pfizer Us Pharmaceutical Group voluntarily recalled Advil PM Caplets due to subpotent drug risks. The recall affects 70,704 bottles distributed nationwide because of out-of-specification test results for Diphenhydramine citrate.
How to tell if you have it
- Brand: Advil
- Product: Advil PM Caplets (Ibuprofen, 200 mg / Diphenhydramine citrate, 38 mg)
- Packaging: 120 count bottle
- NDC: 0573-0164-43
- Lot code: G85041
- Quantity: 70,704 bottles
The hazard
The FDA stated the lot is being recalled because of out-of-specification test results for Diphenhydramine citrate. This constitutes a subpotent drug hazard.
Context
GovInfoNow's records show Pfizer Us Pharmaceutical Group has 3 other recalls on record since 2013-09-04. Other recent recalls of similar products include Bell Pharmaceuticals Carbamide Peroxide 6.5% Recall (2026-06-25), Major Pharmaceuticals Levothyroxine Tablets Recall (2026-07-13), and Bell Pharmaceuticals Clinere Carbamide Peroxide Recall (2026-06-25).